Quantcast

Latest Clinical research Stories

2014-07-29 16:25:54

33 Studies Explore Diverse Ways to Help Patients, Other Stakeholders Make Better-Informed Care Decisions WASHINGTON, July 29, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved $54.8 million in funding to support 33 new patient-centered comparative clinical effectiveness research (CER) projects that will study health conditions and concerns that affect millions of Americans. The approved proposals include...

2014-07-29 08:33:38

NEW YORK, July 29, 2014 /PRNewswire/ -- Recently unveiled at the annual American Society of Clinical Psychopharmacology conference in Hollywood, FL, a new randomized, double-blinded, placebo-controlled human clinical trial conducted by The Brain Institute, at the University of Utah, found that adolescent males experienced increased motor speed and attention after supplementation of citicoline. The trial involved 75 adolescent males over a 28-day period in which the citicoline, a known...

2014-07-29 08:32:54

Phase I Project to Focus on Advanced Molecular Search Models for the Inverse Design Computational Drug Discovery Platform RESEARCH TRIANGLE PARK, N.C., July 29, 2014 /PRNewswire/ -- Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it has been awarded a Phase I grant from the National Science Foundation Small Business Innovation Research (NSF SBIR) program. The grant is valued at $150,000. Cloud...

2014-07-29 08:32:50

PLANTATION, Fla., July 29, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) announced today that it has initiated a Phase 2a clinical trial to evaluate bryostatin for the treatment of patients with Alzheimer's disease (AD). Bryostatin is a potent modulator of the enzyme protein kinase C epsilon (PKCe). In preclinical in vivo models, this effect has been shown to play an important role in slowing or reversing AD and restoring cognition, memory and motor skills. The top-line analysis...

2014-07-29 08:32:38

Recent U.S. FDA 510(K) Clearance and Appointment of New CEO Create Optimal Growth Environment for Company WHEAT RIDGE, Colo., July 29, 2014 /PRNewswire/ -- The BioFusionary Corporation, Inc. (TBC), a medical technology company focused on developing a proprietary electromagnetic induction platform with aesthetic and surgical applications, today announced it entered into an agreement under which TBC will merge with Australia-based Continuation Investments Limited (COT) in an all-stock...

2014-07-29 08:32:31

HAYWARD, Calif., July 29, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) performed a general GMP inspection and a Pre-Approval Inspection (PAI) for RYTARY(TM )at the Company's Taiwan manufacturing facility from July 21 to July 26, 2014. At the conclusion of the inspection, the FDA issued a Form 483 with ten inspectional observations. The Taiwan facility was approved for product manufacturing by the FDA in...

2014-07-29 08:32:30

BELLEVILLE, ON, July 29, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced the submission to the US Food and Drug Administration (FDA) Office of Orphan Products Development, an application for Orphan Drug Designation for its Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory/relapsing high grade non-muscle invasive bladder cancer. The decision to proceed...

2014-07-28 23:04:08

Transparency Market Research has published a new report titled "Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/e-clinical-solution-software-market.html. Albany, New York (PRWEB) July 28, 2014 According to a new market report published by Transparency Market Research "E-Clinical Solution Software Market- Global Industry...

2014-07-28 20:25:54

BOSTON, July 28, 2014 /PRNewswire/ -- Hays Companies of Boston is pleased to announce Melissa Tobler is one of four individuals to date to receive the Validation Institute's Advanced Certification on Critical Outcomes Report Analysis. Intel-GE Care Innovations(TM) launched the Validation Institute to "challenge the status quo of typical healthcare research design principles, with the goal of positively impacting how the industry establishes credibility over time, but also ultimately...

2014-07-28 12:27:54

Hardison's election represents ConvergeHEALTH's commitment to standards-based innovation NEW YORK, July 28, 2014 /PRNewswire/ -- David Hardison, Ph.D., vice president of health services for ConvergeHEALTH by Deloitte, has been elected chairman of the board for the Clinical Data Interchange Standards Consortium, a non-profit working to establish common protocols around the use of clinical research data, particularly as it relates to electronic health records....


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related